Morphine

TRAITEMENT LOCAL DE LA DOULEUR EN COMPLÉMENT DU TRAITEMENT ANTALGIQUE DE FOND DANS LE SOINS DES PLAIES

(plaies inflammatoires, escarres, plaies cancéreuses, ulcères veineux et artériels)

Formules

topique

Stabilité préparation non stérile : 7 jours, préparation stérile : 28 jours. (1-2)

 Prescription à but thérapeutique en l’absence de spécialité équivalente disponible.

 Références bibliographiques :

 

1.Ribeiro, M.D., S.P. Joel and G. Zeppetella, The bioavailability of morphine applied topically to cutaneous ulcers. J Pain Symptom Manage, 2004. 27: 434-9.
2. LeBon, B., G. Zeppetella and I.J. Higginson, Effectiveness of topical administration of opioids in palliative care: a systematic review. J Pain Symptom Manage, 2009. 37: 913-7.
3. Zeppetella G, Paul J, Ribeiro MDC. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 2003;25:555e558.
4. Cialkowska-Rysz, A; Dzierzanowski, T (2019) Topical morphine for treatment of cancer related painful mucosal and cutaneous lesions:a double blind, placebo-controlled cross over clinical trial. Archives of medical  science:AMS. 15:146-151
5. Zeppetella, G; Ribeiro, MD (2005) Morphine in intrasite gel applied topically to painful ulcers Journal of Pain and Symptom management. 29:118-119
6. Guidelines for the use of topical morphine for painful skin ulcers in palliative care. NHS.2012
7. Flock, P (2003) Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. Journal of Pain & Symptom Management. 25 (6) pp547-554